ICU Medical (NASDAQ: ICUI) reported Q1 EPS of $1.68, $1.22 better than the analyst estimate of $0.46. May not be comparable. Revenue for the quarter came in at $248.1 million versus the consensus estimate of $237.12 million.

First Quarter 2017 Results

First quarter 2017 revenue was $247.7 million, compared to $89.9 million in the same period last year. GAAP gross profit for the first quarter of 2017 was $88.9 million, as compared to $49.2 million in the same period last year. GAAP gross margin for the first quarter of 2017 was 36%, as compared to 55% in the same period last year. GAAP net income for the first quarter of 2017 was $55.9 million, or $2.86 per diluted share, as compared to GAAP net income of $18.2 million, or $1.08 per diluted share, for the first quarter of 2016, which were both adjusted from the previously announced adoption of FASB ASU 2016-09, Improvements to Employee Share-based Payment Accounting, effective January 1, 2016.

Adjusted net sales for the first quarter of 2017 was $248.1 million. Adjusted gross profit for the first quarter of 2017 was $111.0 million. Adjusted gross margin for the first quarter of 2017 was 45%. Adjusted diluted earnings per share for the first quarter of 2017 were $1.68 as compared to $1.26 for the first quarter of 2016. Also, adjusted EBITDA was $50.1 million for the first quarter of 2017 as compared to $32.7 million for the first quarter of 2016.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.